Krieger V - Search Results

1

Assessment of executive function in ADHD adolescents: contribution of performance tests and rating scales.

Krieger V, Amador-Campos JA. Krieger V, et al. Child Neuropsychol. 2018 Nov;24(8):1063-1087. doi: 10.1080/09297049.2017.1386781. Epub 2017 Oct 18. Child Neuropsychol. 2018. PMID: 29041835

2

Temperament, executive function, and attention-deficit/hyperactivity disorder (ADHD) in adolescents: The mediating role of effortful control.

Krieger V, Amador-Campos JA, Gallardo-Pujol D. Krieger V, et al. J Clin Exp Neuropsychol. 2019 Aug;41(6):615-633. doi: 10.1080/13803395.2019.1599824. Epub 2019 Apr 21. J Clin Exp Neuropsychol. 2019. PMID: 31007126

3

Interrater agreement on behavioral executive function measures in adolescents with Attention Deficit Hyperactivity Disorder.

Krieger V, Amador-Campos JA, Peró-Cebollero M. Krieger V, et al. Int J Clin Health Psychol. 2019 May;19(2):141-149. doi: 10.1016/j.ijchp.2019.02.007. Epub 2019 Apr 30. Int J Clin Health Psychol. 2019. PMID: 31193139 Free PMC article.

4

Executive functions, Personality traits and ADHD symptoms in adolescents: A mediation analysis.

Krieger V, Amador-Campos JA, Guàrdia-Olmos J. Krieger V, et al. PLoS One. 2020 May 6;15(5):e0232470. doi: 10.1371/journal.pone.0232470. eCollection 2020. PLoS One. 2020. PMID: 32374779 Free PMC article.

5

Clinical presentations of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents: comparison of neurocognitive performance.

Krieger V, Amador-Campos JA. Krieger V, et al. Child Neuropsychol. 2021 Nov;27(8):1024-1053. doi: 10.1080/09297049.2021.1917530. Epub 2021 Apr 30. Child Neuropsychol. 2021. PMID: 33928840

6

A comparison of COVID-19 mortality rates between European and Asian States.

Küpper JH, Jung F, Krieger V, Hufert F. Küpper JH, et al. Among authors: krieger v. Clin Hemorheol Microcirc. 2020;75(1):3-5. doi: 10.3233/CH-209008. Clin Hemorheol Microcirc. 2020. PMID: 32568188 Free PMC article. No abstract available.

7

Herd immunity or suppression strategy to combat COVID-19.

Jung F, Krieger V, Hufert FT, Küpper JH. Jung F, et al. Among authors: krieger v. Clin Hemorheol Microcirc. 2020;75(1):13-17. doi: 10.3233/CH-209006. Clin Hemorheol Microcirc. 2020. PMID: 32538831 Free PMC article.

8

How we should respond to the Coronavirus SARS-CoV-2 outbreak: A German perspective.

Jung F, Krieger V, Hufert FT, Küpper JH. Jung F, et al. Among authors: krieger v. Clin Hemorheol Microcirc. 2020;74(4):363-372. doi: 10.3233/CH-209004. Clin Hemorheol Microcirc. 2020. PMID: 32390611 Free PMC article.

9

Synthesis of Peptoid-Based Class I-Selective Histone Deacetylase Inhibitors with Chemosensitizing Properties.

Krieger V, Hamacher A, Cao F, Stenzel K, Gertzen CGW, Schäker-Hübner L, Kurz T, Gohlke H, Dekker FJ, Kassack MU, Hansen FK. Krieger V, et al. J Med Chem. 2019 Dec 26;62(24):11260-11279. doi: 10.1021/acs.jmedchem.9b01489. Epub 2019 Dec 17. J Med Chem. 2019. PMID: 31762274

10

Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome Inhibitor.

Bhatia S, Krieger V, Groll M, Osko JD, Reßing N, Ahlert H, Borkhardt A, Kurz T, Christianson DW, Hauer J, Hansen FK. Bhatia S, et al. Among authors: krieger v. J Med Chem. 2018 Nov 21;61(22):10299-10309. doi: 10.1021/acs.jmedchem.8b01487. Epub 2018 Nov 8. J Med Chem. 2018. PMID: 30365892 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page